Loading...
Docoh

GT Biopharma (GTBP)

GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based our proprietary TriKE™ NK cell engager platform. Our TriKE™ platform is designed to harness and enhance the cancer killing abilities of a patient's immune system natural killer cells (NK cells). GT Biopharma has an exclusive worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE™ technology.

GTBP stock data

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

15 Aug 22
19 Aug 22
31 Dec 22
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 5.36M 5.36M 5.36M 5.36M 5.36M 5.36M
Cash burn (monthly) 642.67K 300.83K 1M 3.21M 928.67K 1.3M
Cash used (since last report) 1.08M 505.79K 1.69M 5.4M 1.56M 2.19M
Cash remaining 4.28M 4.85M 3.67M -42.09K 3.8M 3.17M
Runway (months of cash) 6.7 16.1 3.7 -0.0 4.1 2.4

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
15 Jul 22 Wendel Bruce Option to purchase Common Stock Common Stock Grant Acquire A No No 2.48 50,000 124K 50,000
15 Jul 22 Wendel Bruce Option to purchase Common Stock Common Stock Grant Acquire A No No 2.48 50,000 124K 50,000
15 Jul 22 Gregory Berk Option to purchase Common Stock Common Stock Grant Acquire A No No 2.48 50,000 124K 50,000
15 Jul 22 Manu Ohri Common Stock Other Acquire J Yes No 0 100,000 0 100,000
15 Jul 22 Manu Ohri Common Stock Other Dispose J No No 0 100,000 0 0
15 Jul 22 Manu Ohri Common Stock Grant Acquire A No No 0 100,000 0 100,000
15 Jul 22 Manu Ohri Option to purchase Common Stock Common Stock Grant Acquire A No No 2.48 200,000 496K 200,000
15 Jul 22 Urban Alan Louis Option to purchase Common Stock Common Stock Grant Acquire A No No 2.48 50,000 124K 50,000
15 Jul 22 Shrotriya Rajesh C MD Option to purchase Common Stock Common Stock Grant Acquire A No No 2.48 361,476 896.46K 361,476
15 Jul 22 Shrotriya Rajesh C MD Option to purchase Common Stock Common Stock Grant Acquire A No No 2.48 50,000 124K 50,000
13F holders Current Prev Q Change
Total holders 0 0
Opened positions 0 0
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 0
13F shares Current Prev Q Change
Total value 0 0
Total shares 0 0
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners Shares Value Change
Largest transactions Shares Bought/sold Change

Financial report summary

?
Competition
PfizerSanofiImmunityBioNkarta

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: assigned, assistance, brought, chain, Comparison, confidence, conflict, consumer, cybersecurity, directly, domestic, economy, energy, environmental, exacerbate, food, fuel, gas, government, grow, higher, Incentive, inflationary, large, Oil, political, released, Russia, supply, transparency, Ukraine
Removed: attributable, notice